This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
BRACAnalysis -1
{
"resourceType": "Observation",
"id": "ob-genetics-3-1",
"text": {
"status": "generated",
"div": "<div><p><b>Generated Narrative with Details</b></p><p><b>id</b>: ob-genetics-3-1</p><p><b>status</b>: final</p><p><b>code</b>: BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal <span>(Details : {LOINC code '21636-6' = 'BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal', given as 'BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal'})</span></p><p><b>subject</b>: <a>Marry Chalmers (MRN: 12345)</a></p><p><b>effective</b>: 26/05/2015 3:30:10 PM</p><p><b>value</b>: Negative <span>(Details : {SNOMED CT code '260385009' = '260385009', given as 'Negative'})</span></p><p><b>method</b>: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc <span>(Details : {http://www.ncbi.nlm.nih.gov/gtr/ code 'GTR000521311.1' = '??', given as 'BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc'})</span></p></div>"
},
"status": "final",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "21636-6",
"display": "BRCA1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal"
}
]
},
"subject": {
"reference": "Patient/example",
"display": "Marry Chalmers (MRN: 12345)"
},
"effectiveDateTime": "2015-05-26T15:30:10+01:00",
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "260385009",
"display": "Negative"
}
]
},
"method": {
"coding": [
{
"system": "http://www.ncbi.nlm.nih.gov/gtr/",
"code": "GTR000521311.1",
"display": "BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc"
}
]
}
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.